Clinical trials Archives - Hearing Practitioner Australia

(From left) Chief investigator, ENT surgeon Professor Stephen O’Leary from The Royal Victorian Eye and Ear Hospital and cochlear implant fellow Dr Phoebe Ramos demonstrating Hear Alert to cochlear implant recipient Sean Kelleher from Bendigo. Image: The Royal Victorian Eye and Ear Hospital.

Cochlear implants

Hear Alert aims to be the first product to safeguard and monitor cochlear health

February 20, 2026

The Australian Government is helping to fund a local invention pioneered by ENT surgeons and scientists that aims to be...

(From left) Raisse Tjoa and Kate Rutledge in the Innovation Centre, displaying the Hearing WB app and related flyer. Image: Hearing Australia.

Research

Translating research into practice at Hearing Australia’s Innovation Centre

by Staff Writer

February 13, 2026

Dr BEC BENNETT, principal research audiologist at the National Acoustic Laboratories, details her experience with converting research into practice at...

EssilorLuxottica's Nuance Audio hearing glasses are available at OPSM and will also be available from some independent audiology and optometry stores in Australia. Image: EssilorLuxottica.

Open ear technology

Studies say ‘significant improvements’ in hearing performance with Nuance Audio Glasses

by Helen Carter

January 20, 2026

Nuance Audio Glasses deliver “consistent benefits for users in everyday communication” according to clinical findings from two studies evaluating their...

Women with nausea and vomiting during pregnancy may have vestibular pathology, the review suggests. Image: Image: Prostock-studio/stock.adobe.com.

Features

What happens to the inner ear during pregnancy? ENT registrar Dr Sara Timms explains

by Staff Writer

January 20, 2026

ENT registrar Dr SARA TIMMS and British otolaryngologist Dr EMMA STAPLETON undertook a systematic review to evaluate the effect of...

Results highlighted the value of incorporating AEPs into clinical assessment protocols to enhance early-stage Alzheimer's disease diagnosis and monitoring. Image: Arlette/stock.adobe.com.

Dementia

Review supports auditory evoked potentials for early Alzheimer’s disease detection

by Helen Carter

December 22, 2025

A systematic review and meta-analysis have confirmed the effectiveness of auditory evoked potentials (AEPs) as biomarkers of Alzheimer’s disease. Researchers...

The company said the drug's protective effect had been demonstrated across multiple continents, tumour types and clinical settings. Image: pingpao/stock.adobe.com.

Chemotherapy induced hearing loss

Another study finds PEDMARQSI reduces hearing loss risk in kids with cancer

by Helen Carter

December 21, 2025

Another small study has found PEDMARQSI reduces the risk of developing hearing loss from cisplatin chemotherapy in children and adolescents...

From left, Bionics Institute CEO Mr Robert Klupacs, Swinburne University Vice-Chancellor and president Professor Pascale Quester and Swinburne vice-president , innovation and enterprise, Dr Werner van der Merwe. Image: Swinburne University.

Research

Strategic alliance for Swinburne and Bionics Institute to accelerate medical device research

by Helen Carter

November 18, 2025

The Bionics Institute will partner with Swinburne University of Technology in Melbourne in a first-of-its-kind collaboration to accelerate the development...

Some gene therapies for hearing loss have used an adeno-associated virus to deliver a functional version of the OTOF gene to the inner ear via a single injection. Image: Ditsaraphan/stock.adobe.com.

Guidelines

First consensus framework on gene therapy for hereditary hearing loss

by Helen Carter

October 31, 2025

Experts from around the world have developed the first international expert consensus on gene therapy for hereditary hearing loss, stating...

CMV is a leading cause of birth defects, hearing loss, and neurodevelopmental disability. Image: Mia.B/peopleimages/stock.adobe.com.

Cytomegalovirus

Moderna to discontinue investigational vaccine against congenital CMV

by Helen Carter

October 29, 2025

Moderna has announced it will discontinue its congenital cytomegalovirus (cCMV) vaccine clinical development program. Mr Stephane Bancel, Moderna CEO, said...

Speakers were (L-R top) Dr Fadwa Alnafjan, Dr Bec Bennett, Dr Jeremy Pinyon. (L-R bottom) Dr Emma Laird, Dr Diana Tang, Dr Jackie Ogier. Images: Macquarie University Hearing.

Hearing Researchers

A bright future: Macquarie University Hearing’s inaugural Hearing Research Symposium

by Helen Carter

October 28, 2025

The strength and impact of hearing research in Australia was highlighted at Macquarie University Hearing’s first Hearing Research Symposium. Led...

From innovation to implementation: Preserving residual hearing in cochlear implants

Clinical trials

Hear Alert aims to be the first product to safeguard and monitor cochlear health

Translating research into practice at Hearing Australia’s Innovation Centre

Studies say ‘significant improvements’ in hearing performance with Nuance Audio Glasses

What happens to the inner ear during pregnancy? ENT registrar Dr Sara Timms explains

Review supports auditory evoked potentials for early Alzheimer’s disease detection

Another study finds PEDMARQSI reduces hearing loss risk in kids with cancer

Strategic alliance for Swinburne and Bionics Institute to accelerate medical device research

First consensus framework on gene therapy for hereditary hearing loss

Moderna to discontinue investigational vaccine against congenital CMV

A bright future: Macquarie University Hearing’s inaugural Hearing Research Symposium

Join our newsletter

Subscribe to our newsletter

About Hearing Practitioner Australia

Popular Topics